Arch Neurol -- Table of Contents (Vol. 53 No. 10, October 1996)

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Table of Contents

ARTICLES

Pseudocervical cord syndrome: a deceptive flumazenil reversible manifestation of hepatic encephalopathy
J. W. McDonald; R. E. Bautista; D. H. Gutmann
Arch Neurol. 1996;53:956.

A pilot study of pentoxifylline in multiple sclerosis
J. E. Friedman; J. Zabriskie; E. Bourganskaia
Arch Neurol. 1996;53:956-957.

Cerebral infarct after rattlesnake bite
M. Cole
Arch Neurol. 1996;53:957-958.

Posterior cortical atrophy: neuropathological correlations
T. A. Ala; W. H. Frey 2nd; H. B. Clark
Arch Neurol. 1996;53:958.

Cavernous sinus syndrome. Analysis of 151 cases
J. R. Keane
Arch Neurol. 1996;53:967-971.
ABSTRACT

Amnesia in acute herpetic and nonherpetic encephalitis
L. Hokkanen; O. Salonen; J. Launes
Arch Neurol. 1996;53:972-978.
ABSTRACT

Screening for cognitive dysfunction in multiple sclerosis
M. R. Basso; S. Beason-Hazen; J. Lynn; K. Rammohan; R. A. Bornstein
Arch Neurol. 1996;53:980-984.
ABSTRACT

Motor neuron disease with parkinsonism
A. I. Qureshi; G. Wilmot; B. Dihenia; J. A. Schneider; D. A. Krendel
Arch Neurol. 1996;53:987-991.
ABSTRACT

Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis
M. Spranger; S. Schwab; S. Krempien; M. Winterholler; T. Steiner; W. Hacke
Arch Neurol. 1996;53:992-996.
ABSTRACT

Genetic factors for the development of Alzheimer disease in the Cherokee Indian
R. N. Rosenberg; R. W. Richter; R. C. Risser; K. Taubman; I. Prado-Farmer; E. Ebalo; J. Posey; D. Kingfisher; D. Dean; M. F. Weiner; D. Svetlik; P. Adams; L. S. Honig; C. M. Cullum; F. V. Schaefer; G. D. Schellenberg
Arch Neurol. 1996;53:997-1000.
ABSTRACT

Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group
M. L. Prevey; R. C. Delaney; J. A. Cramer; L. Cattanach; J. F. Collins; R. H. Mattson
Arch Neurol. 1996;53:1008-1016.
ABSTRACT

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy
G. J. Brewer; V. Johnson; R. D. Dick; K. J. Kluin; J. K. Fink; J. A. Brunberg
Arch Neurol. 1996;53:1017-1025.
ABSTRACT

Crossed aphasia. Functional brain imaging with PET or SPECT
M. Bakar; H. S. Kirshner; R. T. Wertz
Arch Neurol. 1996;53:1026-1032.
ABSTRACT

Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests
D. T. Stuss; N. Meiran; D. A. Guzman; G. Lafleche; J. Willmer
Arch Neurol. 1996;53:1033-1039.
ABSTRACT

Diagnosis of dementia. Methods for interpretation of scores of 5 neuropsychological tests
N. Meiran; D. T. Stuss; D. A. Guzman; G. Lafleche; J. Willmer
Arch Neurol. 1996;53:1043-1054.
ABSTRACT

Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population
W. Reid; G. Broe; H. Creasey; D. Grayson; E. McCusker; H. Bennett; W. Longley; M. R. Sulway
Arch Neurol. 1996;53:1056-1061.
ABSTRACT

The validity of rodent brain-ischemia models is self-evident
M. D. Ginsberg
Arch Neurol. 1996;53:1065-1067.

Rodent models of stroke limitations. What can we learn from recent clinical trials of thrombolysis?
J. Grotta
Arch Neurol. 1996;53:1067-1070.

Alzheimer disease and nonfluent progressive aphasia
J. D. Greene; K. Patterson; J. Xuereb; J. R. Hodges
Arch Neurol. 1996;53:1072-1078.
ABSTRACT